Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

Clinical trial NCT03032380 · COMPLETED

Trial details

NCT number: NCT03032380
Sponsor: Shionogi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Healthcare-associated Pneumonia (HCAP)Hospital Acquired Pneumonia (HAP)Ventilator Associated Pneumonia (VAP)

Start date: 2017-10-24
Primary completion: 2019-02-26
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.